Actavis Totowa Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACTAVIS TOTOWA
ACTAVIS TOTOWA has twenty-two approved drugs.
Summary for Actavis Totowa
| US Patents: | 0 |
| Tradenames: | 17 |
| Ingredients: | 17 |
| NDAs: | 22 |
Drugs and US Patents for Actavis Totowa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Totowa | DESIPRAMINE HYDROCHLORIDE | desipramine hydrochloride | TABLET;ORAL | 071766-001 | Oct 5, 1987 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Actavis Totowa | LAMOTRIGINE | lamotrigine | TABLET;ORAL | 078669-002 | Apr 8, 2011 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Actavis Totowa | TOPIRAMATE | topiramate | TABLET;ORAL | 078637-004 | Feb 27, 2013 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Actavis Totowa | PACLITAXEL | paclitaxel | INJECTABLE;INJECTION | 090130-001 | Dec 9, 2009 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
